Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03642639 · ClinicalTrials.gov registry record · NA
A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms
A NA study of Aneurysms, sponsored by Cerenovus, Part of DePuy Synthes Products.
- Completed
- Registry status
- NA
- Development phase
- 809
- Enrollment target
- 20
- Study locations
NCT03642639: Completed NA study of Aneurysms, sponsored by Cerenovus, Part of DePuy Synthes Products.
NCT03642639 is a NA study of Aneurysms that has completed, run by Cerenovus, Part of DePuy Synthes Products. The registered enrollment target is 809 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03642639, a NA study of Aneurysms, has completed, sponsored by Cerenovus, Part of DePuy Synthes Products.
- COMPLETED
- Registry status
- NA
- Development phase
- 809 participants
- Enrollment target
- 20
- Study locations
Study Summary
A post-market registry evaluating ruptured/unruptured aneurysms treated with MICRUSFRAME and GALAXY coils
Primary Outcome
Number of participants who achieved adequate occlusion as assessed by the independent core lab report of the target aneurysm at 1 year without retreatment was reported. Adequate occlusion was defined as the achievement of a Modified Raymond-Roy classification of the aneurysm at 1 year without retreatment. Modified Raymond-Roy Classification scale is a system used to grade the angiographic results of endovascular treatment of brain aneurysms. Class I represents complete obliteration of the aneury
Conditions Studied
Interventions
- DEVICE MICRUSFRAME and GALAXY coils
Study Locations (20)
New York
- University of Buffalo - Buffalo
- Mount Sinai Hospital - New York
- Stony Brook University - Stony Brook
- Westchester Medical Center - Valhalla
Florida
- University of Florida - Gainesville
- Baptist Medical Center - Jacksonville
- University of Miami - Miami
Illinois
- Rush University - Chicago
- University of Illinois - Chicago
- Javon Bea Hospital - Rockford
California
- Mercy San Juan Medical Center - Carmichael
- University of California Irvine - Orange
Arizona
- University of Arizona - Tucson
Georgia
- Memorial Health University - Savannah
Kentucky
- Norton Healthcare - Louisville
Maine
- Maine Medical Center - Scarborough
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 809 participants |
| Start Date | 2018-08-23 |
| Est. Completion | 2025-06-12 |
| Phase | NA |
What the finished NCT03642639 record still lists
NCT03642639 is an interventional study that assigns participants to a tested intervention. The registered 809 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Aneurysms appearing as the primary indexed condition, and to 1 intervention - of which MICRUSFRAME and GALAXY coils is the first listed.
NCT03642639 names 20 study sites across 12 states, led by New York, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT03642639 about?
NCT03642639 is a clinical study titled "A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms". A post-market registry evaluating ruptured/unruptured aneurysms treated with MICRUSFRAME and GALAXY coils
What is the current status of trial NCT03642639?
This trial is currently completed. It is a NA study. The enrollment target is 809 participants. The study started on 2018-08-23. Estimated completion is 2025-06-12.
What conditions does trial NCT03642639 study?
This clinical trial studies the following conditions: Aneurysms.
What interventions are being tested in trial NCT03642639?
The interventions under investigation include: MICRUSFRAME and GALAXY coils (DEVICE).
Who is sponsoring clinical trial NCT03642639?
This trial is sponsored by Cerenovus, Part of DePuy Synthes Products, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03642639 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03642639's enrollment target sits among peer trials
809 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05519085 · 810 participants · Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- NCT06529094 · 808 participants · NA
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI